Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Leukodystrophy Panel

Transgenomics has launched the Leukodystrophy NGS Panel, which is designed to diagnose individuals with any of the roughly 40 inherited nervous system disorders that comprise the disease. The panel includes 137 genes, including all of those recommended under the Global Leukodystrophy Initiative's diagnostic guidelines.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.